Association Between Exposure to Complementary and Integrative Therapies and Opioid Analgesic Daily Dose Among Patients on Long-term Opioid Therapy

被引:5
|
作者
Black, Anne C. [1 ,2 ]
Zeliadt, Steven B. [3 ,4 ]
Kerns, Robert D. [1 ,2 ]
Skanderson, Melissa [5 ]
Wang, Rixin [2 ]
Gelman, Hannah [3 ]
Douglas, Jamie H. [3 ,4 ]
Becker, William C. [1 ,2 ]
机构
[1] VA Connecticut Healthcare Syst, 950 Campbell Ave,Bldg 35LL, West Haven, CT 06516 USA
[2] Yale Sch Med, New Haven, CT USA
[3] VA Puget Sound Healthcare Syst, Puget Sound, WA USA
[4] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA
[5] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA
来源
CLINICAL JOURNAL OF PAIN | 2022年 / 38卷 / 06期
关键词
nonpharmacologic treatment; chronic pain; opioid; veterans; complementary and integrative health; VETERANS; PAIN; HEALTH; CARE; DISCONTINUATION; LESSONS;
D O I
10.1097/AJP.0000000000001039
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: To describe the association between exposure to selected complementary and integrative health (CIH) modalities and the trajectory of prescribed opioid analgesic dose within a national cohort of patients receiving long-term opioid therapy (LTOT) in the Veterans Health Administration (VHA). Materials and Methods: Using national data from VHA electronic health records between October 1, 2017 and September 30, 2019, CIH use was analyzed among 57,437 patients receiving LTOT within 18 VHA facilities serving as evaluation sites of VHA's Whole Health System of Care. Using linear mixed effects modeling controlling for covariates, opioid dose was modeled as a function of time, CIH exposure, and their interaction. Results: Overall, 11.91% of patients on LTOT used any of the focus CIH therapies; 43.25% of those had 4 or more encounters. Patients used acupuncture, chiropractic care, and meditation modalities primarily. CIH use was associated with being female, Black, having a mental health diagnosis, obesity, pain intensity, and baseline morphine-equivalent daily dose. Mean baseline morphine-equivalent daily dose was 40.81 milligrams and dose decreased on average over time. Controlling for covariates, patients with any CIH exposure experienced 38% faster dose tapering, corresponding to a mean difference in 12-month reduction over patients not engaging in CIH of 2.88 milligrams or 7.06% of the mean starting dose. Discussion: Results support the role of CIH modalities in opioid tapering. The study design precludes inference about the causal effects of CIH on tapering. Analyses did not consider the trend in opioid dose before cohort entry nor the use of other nonopioid treatments for pain. Future research should address these questions and consider tapering-associated adverse events.
引用
收藏
页码:405 / 409
页数:5
相关论文
共 50 条
  • [41] Long-term Opioid Therapy and Overdose in Patients with and without Cancer
    Merlin, Jessica S.
    Black, Anne C.
    Midboe, Amanda M.
    Troszak, Lara
    Asch, Steven M.
    Bohnert, Amy
    Fenton, Brenda T.
    Giannitrapani, Karleen F.
    Glassman, Peter
    Kerns, Robert D.
    Silveira, Maria
    Lorenz, Karl A.
    Becker, William C.
    JOURNAL OF PAIN, 2022, 23 (05): : 60 - 60
  • [42] Monitoring of patients receiving long-term opioid therapy - In response
    Katz, N
    Fanciullo, G
    Vielguth, JE
    ANESTHESIA AND ANALGESIA, 2004, 99 (01): : 304 - 305
  • [43] Deprescribing long-term opioid therapy in patients with chronic pain
    Glare, Paul
    Ashton-James, Claire
    Han, Esther
    Nicholas, Michael
    INTERNAL MEDICINE JOURNAL, 2020, 50 (10) : 1185 - 1191
  • [44] Associations between initial opioid exposure and the likelihood for long-term use
    Hadlandsmyth, Katherine
    Lund, Brian C.
    Mosher, Hilary J.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2019, 59 (01) : 17 - 22
  • [45] Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naive Patients: A Statewide Retrospective Cohort Study
    Deyo, Richard A.
    Hallvik, Sara E.
    Hildebran, Christi
    Marino, Miguel
    Dexter, Eve
    Irvine, Jessica M.
    O'Kane, Nicole
    Van Otterloo, Joshua
    Wright, Dagan A.
    Leichtling, Gillian
    Millet, Lisa M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 (01) : 21 - 27
  • [46] Common and Challenging Behaviors Among Individuals on Long-term Opioid Therapy
    Young, Sarah R.
    Azari, Soraya
    Becker, William C.
    Edelman, E. Jennifer
    Liebschutz, Jane M.
    Roy, Payel
    Starrels, Joanna L.
    Merlin, Jessica S.
    JOURNAL OF ADDICTION MEDICINE, 2020, 14 (04) : 305 - 310
  • [47] National study of discontinuation of long-term opioid therapy among veterans
    Vanderlip, Erik R.
    Sullivan, Mark D.
    Edlund, Mark J.
    Martin, Bradley C.
    Fortney, John
    Austen, Mark
    Williams, James S.
    Hudson, Teresa
    PAIN, 2014, 155 (12) : 2673 - 2679
  • [48] Long-Term Opioid Therapy for Chronic Pain
    Lubrano, Michael
    Wanderer, Jonathan P.
    Ehrenfeld, Jesse M.
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (02) : 147 - 147
  • [49] EXPLORING FACTORS ASSOCIATED WITH LONG-TERM OPIOID THERAPY IN CANCER SURVIVORS: AN INTEGRATIVE REVIEW
    Jones, Katie
    Wood, Lisa
    Fu, Mei
    Lee, Christopher
    ONCOLOGY NURSING FORUM, 2021, 48 (02) : 40 - 40
  • [50] Exploring Factors Associated With Long-Term Opioid Therapy in Cancer Survivors: An Integrative Review
    Jones, Katie Fitzgerald
    Fu, Mei R.
    Merlin, Jessica S.
    Paice, Judith A.
    Bernacki, Rachelle
    Lee, Christopher
    Wood, Lisa J.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2021, 61 (02) : 395 - 415